Yahoo Canada Web Search

Search results

  1. The Dividend Payable/Unclaimed dividend as on September 30, 2022 includes Tk. 44,812K relating to year 2020-21 which has been paid but not yet claimed. The remaining balance relates to dividend for prior years unclaimed to date. For the Period For the Period July - September 2022 July - September 2021. 10.

  2. Oct 11, 2024 · Trading at 68.4% below our estimate of its fair value. Earnings are forecast to grow 15.64% per year. Earnings grew by 19.1% over the past year. Pays a high and reliable dividend of 4.77%. Trading at good value compared to peers and industry. Risk Analysis. No risks detected for BXPHARMA from our risk checks.

    • ৳146.20
    • 0.60
    • ৳64.20
    • ৳67.50
  3. www.beximco.com › media › Reportswww.beximco.com

    www.beximco.com

  4. Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. BPL is the largest exporter of generic drugs in the country and its state-of-the-art manufacturing facilities are already certified by major global regulatory authorities like TGA, GCC and ANVISA, while awaiting audits and approvals by US FDA ...

  5. en.wikipedia.org › wiki › BEXIMCOBEXIMCO - Wikipedia

    In 2023, BEXIMCO Group inaugurated Teesta Solar Limited. [15] However, the plant started supplying power to the national grid in December 2022. The plant has 520,000 solar panels at 600 acres of land at Tarapur Union. The plant has the capacity to produce 200MW of electricity. [16] The plant is located on the bank of the Teesta River. [15]

  6. Apr 27, 2022 · Beximco Limited has posted another stellar growth in sales and profits in the January-March quarter of fiscal 2021-22. Its total sales grew by 69% to reach Tk1,991 crore in the three months through March, against Tk1,179 crore over the same period a year ago, the company said in its quarterly financial statement.

  7. Jan 30, 2023 · Beximco Pharmaceuticals Ltd (BPL) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others.

  8. People also ask

  1. People also search for